Keywords: ligand, 3rd, quarter, results, pharmaceuticals, revenues, third
Ligand 3rd quarter results
Article | 27 November 1995
- Ligand Pharmaceuticals' revenues in the 1995 third quarter almost doubled to $6.6 million. For the nine months, revenues increased 95.3% to $16.6 million. The ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
